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cense.Abstract Purpose: To evaluate the role of diffusion-weighted imaging (DWI) in differentiating
the various causes of enlarged neck lymph nodes.
Materials and methods: Thirty-four patients with enlarged neck lymph nodes clinically suggestive
of malignancy underwent DWI with b values (0 and 1000). Apparent diffusion coefﬁcient (ADC)
maps are generated from DWI and ADC values were calculated for the enlarged lymph nodes
and compared with histopathological results.
Results: The patients were divided into nine patients with benign neck lymphadenopathy, 14 patients with
metastasis fromhead and neck cancer and 11 patients with nodal lymphoma. ThemeanADCof the benign
neck lymph nodes (1.51 ± 0.36 · 103 mm2/s) was signiﬁcantly higher than those of the metastatic
(0.92± 0.13 · 103 mm2/s) and lymphomatous (0.74± 0.14 · 103 mm2/s) lymph nodes (p<0.0001)
and the mean ADC of the metastatic nodes was signiﬁcantly higher than that of nodal lymphoma
(p=0.04). The mean ADC of well- and moderately differentiated metastasis (0.98 ± 0.14 · 103 mm2/
s) was signiﬁcantly higher than that of poorly differentiated metastasis (0.83± 0.06 · 103 mm2/s)
(p=0.03). The mean ADC of non-Hodgkin lymphoma (0.65 ± 0.06 · 103 mm2/s) was signiﬁcantly
lower than that of Hodgkin lymphoma (0.86 ± 0.11 · 103 mm2/s) (p=0.004). The best threshold for
differentiating malignant from benign lymph nodes was 1.15 · 103 mm2/s.
Conclusion: DWI is a non-invasive technique that can help in the identiﬁcation of the cause of enlarged
neck lymph nodes.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
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174 T.F. Taha Ali1. Introduction
Detection of neck lymph nodes and their differentiation into be-
nign or malignant are important especially in patients with head
and neck cancer for staging, treatment planning and follow-up
of cancer (1–5). Conventional imaging depends upon the mor-
phologic criteria of the lymph node including the maximum
short axial diameter, presence of necrosis, loss of LN hilum, het-
erogeneous enhancement, and perinodal inﬁltration (6–10).
Ultrasound (US), computed tomography (CT) and mag-
netic resonance (MR) can be used in the detection of enlarged
cervical nodes; however, they cannot accurately differentiate
benign from malignant lymph nodes. Metabolic imaging using
single photon emission-CT (SPECT) and positron emission
tomography (PET) can help in this differentiation but they
are limited by low spatial resolution and variable physiological
ﬂuro-deoxyglucose (FDG) uptake in anatomical structures
and inﬂammatory lymph nodes. Ultrasound guided ﬁne needle
aspiration cytology (FNAC) is invasive with false negative re-
sults due to operator-dependency (1,11–13).
Diffusion-weighted MRI (DWI) is a non-invasive func-
tional technique which allows the characterization of tissues
and lesions by difference in microstructure based on the anal-
ysis of water motion as architectural changes in the water mol-
ecule movement will alter the apparent diffusion coefﬁcient
and the signal intensity in DWI and apparent diffusion coefﬁ-
cient maps (7–10,14–15).
The purpose of our study was to evaluate the potential role
of DWI for differentiation between malignant and benign neck
lymph nodes.2. Materials and methods
2.1. Patients
Our prospective study included 34 patients (19 male and 15 fe-
male patients with their mean age 51.4 ± 9.6 years) with en-
larged neck lymph nodes clinically suggestive of malignancy
before they underwent histopathological examination by either
neck dissection (n= 11), surgical (n= 14) or core biopsy
(n= 9). Institutional review board approval and informed
consent was taken from all patients.Fig. 1 ROI application at ADC map to calculate ADC values.2.2. MR imaging protocol
MR imaging was performed with the use of a 1.5-T MR
(Achieva, Philips Medical Systems, Netherland B.V.) by using
a standard head and neck coil. After localizer images in axial,
coronal and sagittal planes. Conventional images were obtained
including T1-weighted images (500–600/10 repetition time ms/
echo time ms) and T2-weighted fast spin echo images (3000/
100) were obtained in the axial and coronal planes, with a sec-
tion thickness of 3–4 mm, an intersection gap of 1 mm, a ﬁeld
of view (FOV) of 250 mm and a ﬂip angle of 90. T1-weighted
images with and without fat saturation were performed after
the administration of 15 ml of gadopentetate dimeglumine.
Diffusion-weighted images were obtained in the axial plane
before contrast administration, 3–4 mm slice thickness, 1 mm
intersection gap, FOV 250 mm, repetition time/echo time
2000–2600 ms/70 ms. The diffusion sensitizing gradient was
applied in all three orthogonal planes (X, Y, Z) using b values(0 and 1000 s/mm2). Apparent diffusion coefﬁcient (ADC)
maps were automatically calculated by MRI machine software
and included in the sequence.
2.3. Image analysis and data interpretation
MR images were blindly evaluated without knowing the histo-
pathological type of the node. Conventional T1 and T2-
weighted images were assessed for the evaluation of the lesion.
ADC maps generated from DWI were used for the measure-
ment of ADC values.
In each patient, the largest abnormal node was selected for
evaluation. The nodal ADC value was obtained by drawing a
region of interest (ROI) covering as much as possible of the
pathologic node (Fig. 1) in all sections in which it was present
and averaging the results. In this study, we excluded the necro-
tic areas from analysis to avoid a false high ADC due to the
low amount of intact tumoral cells (8).
The results of the measurements on MRI were compared
with the results of the pathological examination of the biopsy.
To ensure that the surgically removed node is the same as-
sessed at MRI, we did topographic correlation by recording
the maximum short axial nodal diameter and the exact loca-
tion of each lymph node as well as the relation to the surround-
ing anatomic structures.
2.4. Statistical analysis
According to the histopathological analysis of the enlarged
lymph nodes, our patients were divided into benign, metastasis
and lymphoma. Statistical analysis was done using SPSS ver-
sion 10. The mean and standard deviations for ADC were
calculated for the three groups. One way analysis of variance
(ANOVA) and post hoc analysis were used to test the
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types. Metastasis was subdivided into well- or moderately dif-
ferentiated and poorly differentiated types while lymphoma
was subdivided into Hodgkin and non-Hodgkin types. T-test
was used to assess the difference in ADC values between well-
and moderately differentiated and poorly differentiated metas-
tasis as well as Hodgkin and non-Hodgkin lymphomas.
We used the receiver operating characteristic (ROC) curve
to evaluate the diagnostic capability of the ADC value for
use in the differentiation between benign and malignant
(metastasis and lymphoma) lymphadenopathy, and then we
used multiple thresholds of ADC values in order to select the
best one (cutoff value) determined by Kappa test for differen-
tiating benign from malignant nodes. The probability (p value)
was considered signiﬁcant when p< 0.05.
3. Results
Thirty-four patients with suspected malignant neck lymphade-
nopathy underwent MRI including diffusion-weighted images
followed by histopathological examination after either neck
dissection, surgical or core biopsy. According to histopatholo-Table 1 Mean ADC values in the different types of neck
lymphadenopathy.
Number
of cases
ADC values
(Mean ± SD)·103
(mm2/s)
Benign 9 1.51 ± 0.36
Metastasis 14 0.92 ± 0.13
Well and moderately
diﬀerentiated
8 0.98 ± 0.14
Poorly diﬀerentiated 6 0.83 ± 0.06
Lymphoma 11 0.74 ± 0.14
Non-Hodgkin lymphoma 5 0.65 ± 0.06
Hodgkin lymphoma 6 0.86 ± 0.11
Fig. 2 Box plots of the ADC values of benign lymphagical results the patients were divided into nine patients with
benign neck lymphadenopathy (lymphadenitis), 14 patients
with metastasis from head and neck cancer (eight patients with
well- and moderately differentiated and six patients with
poorly differentiated carcinomas) and 11 patients with nodal
lymphoma (ﬁve were non-Hodgkin and six were Hodgkin lym-
phomas) (Table 1). The mean short axis of examined lymph
nodes was 3.2 cm (range = 1.3–7.4 cm).
The mean ADC values of the benign, metastasis and lym-
phoma groups were 1.51 ± 0.36 · 103, 0.92 ± 0.13 · 103
and 0.74 ± 0.14 · 103 mm2/s, respectively (Table 1 and ﬁg.
2). Using one way analysis of variance (ANOVA) and post
hoc analysis the ADC values of the benign neck lymph nodes
(Fig. 3) were signiﬁcantly higher than those of the metastasis
lymph nodes (Fig. 4) and nodal lymphoma (p< 0.0001) and
the ADC values of the metastatic lymph nodes were signiﬁ-
cantly higher than those of nodal lymphoma (p= 0.04).
The meanADC of well- andmoderately differentiated metas-
tasis (0.98 ± 0.14 · 103 mm2/s) was higher than themeanADC
of poorly differentiated metastasis (0.83 ± 0.06 · 103 mm2/s)
with a statistically signiﬁcant difference between the ADC values
of well and poorly differentiated metastasis (t= 2.42 and
p= 0.03) (Table 2).
The mean ADC of non-Hodgkin lymphoma
(0.65 ± 0.06 · 103 mm2/s) (Fig. 5) was lower than the mean
ADC of Hodgkin lymphoma (0.86 ± 0.11 · 103 mm2/s)
(Fig. 6) with a statistically signiﬁcant difference between the
ADC values of Hodgkin and non-Hodgkin lymphoma
(t= 3.76 and p= 0.004) (Table 2).
Receiver operating characteristic (ROC) curve was used to
evaluate the diagnostic capability of the ADC value in differ-
entiating benign from malignant (metastasis and lymphoma)
lymph nodes (ﬁg. 7). The area under the curve (AUC) was
0.96 with CI (0.89–1.02), std error = 0.034 and p< 0.0001.
The ADC value of 1.15 · 103 mm2/s was used as a cutoff va-
lue for differentiation benign from malignant lymph nodes
with sensitivity, speciﬁcity, positive predictive value (PPV),
negative predictive value (NPV), Kappa test and p value
96%, 88.9%, 96%, 88.9%, 0.84 and <0.0001, respectively.denopathy, metastatic nodes and nodal lymphoma.
Fig. 3 Lymphadenitis: small right submandibular lymph node (*): axial T1WI (a) and T2WI (b). At DWI b 1000 (c) the lymph node is of
low signal intensity and it is of high signal intensity at ADC map (d). ADC value is 1.46 · 103 mm2/s.
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The presence of lymph node metastases is an important prog-
nostic factor in patients with head and neck cancer as this sig-
niﬁcantly impacts the treatment outcome (16,17). Ultrasound,
contrast-enhanced computed tomography and contrast en-
hanced MRI allow the detection of enlarged neck lymph
nodes; however, none of these methods reaches the ideal accu-
racy (11,14). SPECT (single photon emission CT) and PET
(positron emission tomography) give functional information
but they are invasive, expensive, less available and with a
relatively low spatial resolution (18–20).
Diffusion of water protons in biologic tissues derives from
the diffusion of extracellular water protons, transport of water
protons through the cell membranes, and diffusion of intracel-
lular water protons. The motion is disturbed by ﬁbers, intracel-
lular organelles, and macromolecules in the tissues. Since the
water protons in each portion in the tissue contribute differ-
ently to the diffusion of the tissue, any architectural changes
in the tissue, including the change in the proportion of extra-
cellular to intracellular water protons, will alter the diffusion
coefﬁcient of the tissue (21). Thus, DWI can provide informa-
tion about the tumor biology and physiology and differentiate
benign from malignant tumors with progressive decrease in theADC value from benign lesions to non-invasive and invasive
carcinoma and there is a relationship between ADC and tumor
cellularity (22).
Our study included 34 patients with enlarged neck lymph
nodes. They were nine patients with benign lymphadenopathy
(lymphadenitis), 14 patients with metastasis from head and neck
cancer and 11 patients with nodal lymphoma. ThemeanADCval-
ues of the benign, metastasis and lymphoma groups were
1.51 ± 0.36 · 103, 0.92 ± 0.13 · 103 and 0.74 ± 0.14 · 103
mm2/s, respectively.
The ADC values of the benign neck lymph nodes were
signiﬁcantly higher than those of metastatic nodes and nodal
lymphoma. Furthermore, the ADC values of the metastatic
lymph nodes were signiﬁcantly higher than those of nodal
lymphoma. This is in agreement with several earlier studies
(23–27).
Razek et al. (23) found that the mean ADC value of metastatic
(1.09 ± 0.11 · 103 mm2/s) and lymphomatous (0.97 ± 0.27 ·
103 mm2/s) lymph nodes was signiﬁcantly lower than that of be-
nign (1.64 ± 0.16 · 103 mm2/s) cervical lymph nodes (p< 0.04).
Perrone et al. (24) showed that the mean ADC value of metastatic
and lymphomatous nodes (0.85 · 103 mm2/s) was signiﬁcantly
lower than the mean value of benign nodes (1.448 · 103 mm2/s)
(p< 0.01). Bondt et al. (25) reported that the ADC values of
Fig. 4 Metastatic lymph node: axial T2WI (a) shows multiple amalgamated left cervical lymph nodes causing right side tracheal
deviation. Post-contrast T1WI (b) shows heterogeneous enhancement. At DWI b 1000 (c) the lymph nodes are of high signal intensity and
it is of low signal intensity at ADC map (d). ADC value is 0.83 · 103 mm2/s.
Table 2 T-test and p value comparison between ADC values
in different types of metastasis and lymphoma.
Well and moderately
diﬀerentiated versus poorly
diﬀerentiated metastasis
Hodgkin versus
non-Hodgkin lymphoma
T-test 2.42 3.76
p value 0.03 0.004
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benign lymph nodes with mean values of 0.85 ± 0.19 · 103
and 1.2 ± 0.24 · 103 mm2/s, respectively. King et al. (26) on
their study on malignant cervical lymphadenopathy found that
the ADC of metastasis from squamous cell carcinoma was signif-
icantly higher than the ADC value of lymphoma. In addition,
Sumi et al. (27) concluded that the ADC values were the highest
in metastatic nodes and the lowest in lymphoma. Perrone et al.
(24) explained the reduced ADC value in lymphoma by the in-
creased cellularity and the reduced extracellular space. Sumi et
al. (28) found also that nodal lymphomas had low levels of ADCs
(0.223 ± 0.056 · 10–3 mm2/s) relative to those of benign lymphad-enopathy (p< 0.05). On the other hand they concluded that the
ADC of the metastatic nodes (0.410 ± 0.105 · 103 mm2/s) was
signiﬁcantly (p< 0.01) higher than that of the inﬂammatory
nodes (0.302 ± 0.062 · 10–3 mm2/s) and this may be because
48%of theirmetastatic lymph nodes had central necrosis resulting
in a large variability in the ADC values of these nodes.
In patients with well- and moderately differentiated metasta-
sis, the mean ADC value (0.98 ± 0.14 · 103 mm2/s) was signif-
icantly higher than the mean ADC value of poorly differentiated
metastasis (0.83 ± 0.06 · 103 mm2/s). This is in agreement with
the previous study (23) which showed that poorly differentiated
metastatic lymph nodes had signiﬁcantly lower ADC values
(mean 0.89 ± 0.12 · 103 mm2/s) than well- andmoderately dif-
ferentiated lesions (mean 1.13 ± 0.11 · 103 mm2/s) (p< 0.02).
This is also in consistent with the study carried out by Sumi
et al. (28) who attributed this difference to increased nucleus-
to-cytoplasm ratio and hypercellularity in poor differentiated
carcinoma reduce the extracellular matrix and the diffusion
space of water protons in the extracellular and intracellular
dimensions. However King et al. (26) reported that there was
no signiﬁcant difference in the ADC values between poorly
differentiated squamous cell carcinoma (SCC) and well- and
moderately differentiated SCC.
Fig. 5 Non-Hodgkin lymphoma: axial T1W1 (a), T2WI (b) and post contrast T1WI (c) show multiple bilateral enlarged cervical lymph
nodes. At DWI b 0 (d) and b 1000 (e) the nodes are hyperintense and they are of low signal intensity at ADC map (f). ADC value is
0.59 · 103 mm2/s.
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lymphoma (0.65 ± 0.06 · 103 mm2/s) was signiﬁcantly lower
than the mean ADC of Hodgkin lymphoma (0.86 ± 0.11 ·
103 mm2/s) (t= 3.76 and p= 0.004). This is in agreement with
Razek et al. (23) who demonstrated that the mean ADC value
was lower in patients with non-Hodgkin lymphoma (mean0.93 ± 0.07 · 103 mm2/s) compared with patients with
Hodgkin disease (mean 1.03 ± 0.07 · 103 mm2/s).
The best ADC threshold value for distinguishing benign
and malignant nodes was 1.15 · 103 mm2/s with sensitivity,
speciﬁcity, PPV, NPV, Kappa test and p value 96%, 88.9%,
96%, 88.9%, 0.84 and <0.0001, respectively. The area under
Fig. 6 Hodgkin lymphoma: axial T1WI (a), T2WI (b) and coronal T2WI (c) shows a large well deﬁned right cervical lymph node. At
DWI b 0 (d) and b 1000 (e) the lymph node is hyperintense and it is of low signal intensity at ADC map (f). ADC value is 0.72 · 103 mm2/
s.
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acteristic (ROC) curve of the ADC value was used for the dif-
ferentiation of benign from malignant lymph nodes.
Perrone et al. (24) reported that the best threshold value for
differentiating malignant from benign nodes was 1.03 ·
103 mm2/s, obtaining a sensitivity of 100% and a speciﬁcity of92.9%. The area under (ROC) was 0.983. Razek et al. (23) used
an ADC value of 1.38 · 103 mm2/s as a threshold value for dif-
ferentiating malignant from benign lymph nodes, the best results
were obtained with an accuracy of 96%, sensitivity of 98%, spec-
iﬁcity of 88%, PPV of 98.5%andNPV of 83.7%. The area under
the curve was 0.955. Bondt et al. (25) found that the optimal
Fig. 7 Receiver operating characteristic (ROC) curve of the
ADC value for discrimination between benign and malignant
(metastatic and lymphoma) lymph nodes. The area under the
curve is 0.96.
180 T.F. Taha AliADC threshold value for the diagnosis of malignant cervical
lymph nodes was 1.0 · 103 mm2/s with sensitivity and speciﬁc-
ity of 92.3% and 83.9%, respectively.
Although the spine is probably the most suitable reference
tissue for ADC normalization purposes, we did not report nor-
malized ADCs to the spine as the spinal cord echo-planar
imaging is hindered by strong susceptibility inﬂuences––in-
duced mainly by the surrounding osseous elements of the
spinal column––that introduce additional variability in ADC
calculations (29).
The current study had some limitations such as increasing
the b value in order to improve the sensitivity of diffusion,
leads to the reduction of the signal-to-noise ratio and that
hampers the ADC measurement on the smallest nodes. In
the current study, a maximum b value of 1000 s/mm2 was used.
A further limitation was the relatively small study cohort; sta-
tistical tests were performed on the number of patients rather
than on the number of involved lymph nodes to avoid con-
founding effect and inﬂuence of multiple nodes per patient
on the result.
Further advances of DW technique including using the
ADC histogram-based approach besides the creation of
parametric maps may help in differentiating between the
viable and necrotic parts of tumors. Therefore, it can select the
best biopsy site and assess tumor viability in post-radiation
follow-up (30).
5. Conclusion
The ADC values of lymphoma are less than the ADC values of
metastasis which are less than the ADC values of benign en-
larged neck lymph nodes. The ADC values of poorly differenti-
ated metastasis are less than the ADC values of well- and
moderately differentiated metastasis. The ADC values of non-Hodgkin lymphoma are less than those of Hodgkin lymphoma.
The best threshold for differentiating malignant from benign
lymph nodes is 1.15 · 103 mm2/s. Although future improve-
ments and advances are still to be expected, DWI, which is a
non-invasive practical technique, can help effectively in the dif-
ferentiation of benign from malignant lymph nodes.References
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